Skip to main content
logo
Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China flag China · Delayed Price · Currency is CNY
4.130
-0.040 (-0.96%)
Oct 28, 2026, 11:29 AM CST

SHA:600572 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
456.74474.36622.42591.57358.122,017
Depreciation & Amortization
332.4336.49344.94324.35277.48286.68
Other Amortization
22.3918.319.058.779.3817.41
Loss (Gain) From Sale of Assets
-4.89-4.89-16.91-35.68-36.51-43.18
Asset Writedown & Restructuring Costs
26.8126.811.827.182.3396.67
Loss (Gain) From Sale of Investments
-105.25-105.25-96.8761.31202.15-1,881
Provision & Write-off of Bad Debts
1.031.011.041.070.2436.57
Other Operating Activities
359.4653.299.85155.42163.86269.06
Change in Accounts Receivable
156.52156.52138-271.4447.95-360.47
Change in Inventory
7.227.2219.2-244.97-111.02-158.76
Change in Accounts Payable
-40.85-40.85-145.41358.69246.19341.51
Change in Other Net Operating Assets
10.9810.982426.364.7930.52
Operating Cash Flow
1,231942.611,013898.641,155891.23
Operating Cash Flow Growth
13.42%-6.91%12.67%-22.23%29.65%-28.68%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-224.28-147.26-290.63-209.14-291.75-581.42
Sale of Property, Plant & Equipment
7.4325.5323.8396.34164.0121.02
Cash Acquisitions
---8.79-206.31-
Divestitures
41.02----0.011,479
Investment in Securities
-447.2922.6222.74-207.1394.24168.48
Other Investing Activities
29.7234.5732.5622.0928.720.31
Investing Cash Flow
-593.41-64.54-211.5-289.05-211.111,087

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-282.03750.271,7551,7601,912
Total Debt Issued
155.14282.03750.271,7551,7601,912
Long-Term Debt Repaid
--409.27-1,565-1,716-2,060-2,791
Lease Payments
------4.87
Net Debt Issued (Repaid)
-200.18-127.25-815.1138.44-300.45-879.27
Issuance of Common Stock
55.355.5248.7-1.5-
Repurchase of Common Stock
---299.99---
Common Dividends Paid
-377.07-383.64-523.54-420.13-490.35-85.01
Other Financing Activities
-24.46-38.09-324.96-337.4-135.41-61.74
Financing Cash Flow
-546.41-493.45-1,915-719.08-924.71-1,026

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-6.52-1.555.112.999.110.05
Net Cash Flow
84.92383.06-1,109-106.5128.77952.21

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,007795.35721.9689.5863.73309.8
Free Cash Flow Growth
16.89%10.17%4.70%-20.17%178.80%-60.75%
Free Cash Flow Margin
14.75%12.29%11.08%10.24%14.39%4.72%
Free Cash Flow Per Share
0.400.320.290.270.340.12
Levered Free Cash Flow
579.7720.52516.7664.78602.51-18.09
Unlevered Free Cash Flow
580.81725.39529.7687.53633.4327.67
Free Cash Flow After Leases
1,007795.35721.9689.5863.73304.94

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
690.96646.27518.05722.62562.67619.14
Change in Working Capital
142.55142.5547.18-215.36178.4391.26